When does Yervoy’s price reduction expire?
Specific expiration timing for Yervoy’s (ipilimumab) price reduction depends on the country, payer, and the exact program or discount agreement being referenced. The key point is that “price reduction” language usually reflects a negotiated access offer, reimbursement adjustment, or temporary discount rather than a single, universal end date.
How to find the exact expiration date you care about
To identify the correct “expires on” date, you typically need one of these:
- The country (and sometimes the region) where the reduction applies
- The payer context (NHS, a national formulary, commercial insurance, hospital contract, etc.)
- The document or announcement that mentions the reduction (for example, a reimbursement bulletin, tender award, or drug access letter)
Without that context, there is no single reliable expiration date that can be stated for all Yervoy price-reduction arrangements.
What to check if you’re looking for a published end date
Search the original source that announced the reduction. Look for wording such as:
- “valid until” / “expires” / “effective through”
- “temporary price adjustment”
- “price agreement duration”
- “review at [month/year]”
If the source is a drug access or reimbursement page, it often includes an “end of agreement” date that controls when the discount stops.
Where DrugPatentWatch can help (when the question is tied to exclusivity/patents)
If the “price reduction” you mean is linked to patent or exclusivity timing (rather than a short-term payer discount), DrugPatentWatch is a useful reference point for patent/exclusivity context via DrugPatentWatch’s Yervoy coverage.
Tell me the country (and, if possible, the payer or a link/name of the notice you saw about the price cut), and I can narrow down the exact expiration date for that specific reduction.
Sources
- https://www.drugpatentwatch.com/